Navigation Links
Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life

e colitis.

PENTASA is generally well tolerated and most side effects are mild. In worldwide clinical studies, the most common side effects -- diarrhea, headache, nausea, abdominal pain, upset stomach, vomiting, and rash -- occurred less often with PENTASA than with a sugar pill. As with other medications, some serious side effects may occur. You should not take PENTASA if you are allergic to salicylates, such as aspirin. Tell your doctor if you have problems with your liver or kidneys. While taking PENTASA, visit your doctor periodically. If you have any questions about PENTASA, please talk to your doctor.

SHIRE PLC

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire believes that a carefully selected portfolio of products with a strategically aligned and relatively small-scale sales force will deliver strong results.

Shire's focused strategy is to develop and market products for specialty physicians. Shire's in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe.

For further information on Shire, please visit the Company's website: http://www.shire.com.

    For further information please contact:


    Media         Amanda Widtfeldt (GolinHarris)              +1 312 729 4264

                  Matthew Cabrey (Shire)                      +1 484 595 8248

GIULIANI SpA

Giuliani SpA, founded in 1889, is a privately owned specialty pharmaceutical company strategica
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
2. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
3. Long-Term Extension of Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement Through Two Years of Follow-Up
4. Analysis of Ulcerative Colitis (UC) Remission Rates from Long-term Safety Study of Lialda (mesalamine) Presented at DDW
5. Callisto Intends to Move Guanilib into Clinical Trials in Ulcerative Colitis
6. New Survey Finds Troubling Data on American Asthma Sufferers
7. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
8. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
9. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
10. International Movement Disorder Specialists Receive New Information About the Use of Once-Daily Azilect in the Treatment of Parkinsons Disease
11. New Study Analyses Confirm Once-Daily Seroquel XR Extended-Release Tablets as Effective Treatment for Schizophrenia

Post Your Comments:
(Date:11/25/2009)... SANDIEGO,Nov.25/PRNewswire-FirstCall/--NuVasive,I...evelopingproductsforminimallydisruptivesurgicaltre...nferencecallonMonday,November30,2009,at5:30p.m.ET/...esrelativetoreimbursementfortheCompany,sproductsan...questionandanswersession.Thedial-innumbersare1-877...
(Date:11/25/2009)... NEWYORK,Nov.25/PRNewswire/--Reportlinker.comannou...talogue: ,, PainManagement-GlobalTrends ,...gement---Global-Trends.html ,, Widespreadavail...nics,andtheadventofnewdrugshaveacceleratedthepaceo...andreimbursementstructurecontinuetoshapedemandfors...
(Date:11/25/2009)... DELFT,TheNetherlandsandJOHANNESBURG,November25/PR...andPyxisDiscoveryannouncedtoday,thattheyhavesigned...es,services. , Pyxis,sworldclasscomputational...thiThemba,sservicedivisiontoprovidemedicinaland,sy...Pyxis,internationalclientnetwork.iThembaPharmaceu...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Moderate Drinking Guards the Heart 61733 1Moderate Drinking Guards the Heart 61733 2Moderate Drinking Guards the Heart 61733 3Highlighting racial disparities increases coverage and effectiveness of health news 61731 1Highlighting racial disparities increases coverage and effectiveness of health news 61731 2Patients weight not linked to success of fibroid surgery 61729 1Patients weight not linked to success of fibroid surgery 61729 2
...ation for Cancer Research,(AACR) Annual Meeting -,...iotech Inc., a,privately held biopharmaceutical co...ucts focused on cancer, today announced results,of... studies,conducted to evaluate the potential for c...eutic, Proxinium(TM), with first-line,standard of ...
...e/ -- Micell,Technologies announced today that the...ercritical fluid (SCF) surface modification,techno...ty for,Biomaterials 2007 Annual Meeting, April 19-...ribe use of Micell and PNNL,s, 2006 R&D,100 Aw...ng stents,containing crystalline drugs, such as si...
Other Medicine Technology:Viventia biotech reports synergystic effect of its Proxinium,antibody in combinaton with chemotherapy and radiation 2Viventia biotech reports synergystic effect of its Proxinium,antibody in combinaton with chemotherapy and radiation 3Micell Technologies Presents Data on Novel Drug-Eluting Stents 2Micell Technologies Presents Data on Novel Drug-Eluting Stents 3
(Date:11/26/2009)...r thrill when on an emotional rollercoaster, study...News) -- Call it the fear factor meets the jubilan...ators -- especially those who root for the winning... closely contested match and victory was in doubt,..., Chew on that this Thanksgiving weekend as you,re...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Cen...allas , is one of a growing number of physicians w...ing sites to connect with individuals who are inte...morbid obesity. Dr. Kim is utilizing Facebook to s... his practice with the community. , ...
(Date:11/26/2009)... Benton Communications announces a highly...em for retailers struggling to make an economic re...r 26, 2009 -- Flu fears is the type of challenge t...cy room, according to Dr. David Benton, business g...ness growth system – The Rfactor Intensive ...
(Date:11/25/2009)...nn.,Nov.25/PRNewswire-USNewswire/--Whenmostpeopleh...practorcanalsogivepatientsthehelptheyneed.TMJstand...w(mandible)contacts/connectswithyourskull(temporal...Jdysfunctionarepainwithchewing,clickingorpoppingof...nctionincluding:headaches,fatigue,sleepdisturbance...
(Date:11/25/2009)...LE,Calif.,Nov.25/PRNewswire-FirstCall/-- OnyxPhar...hecompanywillhosttwoinvestoreventsinDecember: ,...T/10:00a.m.ET ,, Principalinvestigatorswilldi...psedand/orrefractorymultiplemyeloma,asfeaturedatth...andExpositioninNewOrleans,LA.Theteleconferencewill...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...Delaware scientists has revealed that non-contact ...ain functions . At UD's Human Performance ... measuring how people mentally prepare and react t...8 universities during the preseason. This testing ...
...tomy, or removal of the tonsils, none reported an ...ing the procedure . Together with the sense o... of taste contributes considerably to flavor perce...le. The sense of taste shows little deteriora...
...dress gender barriers to careers in medical resear...ey findings from the year-long Women in Academic M...ence. A preliminary report states that: ...hools are women, Only one in ten (11%) clinical pr...
...great captive audience for smoking cessation effor...e researchers found that when smokers become hospi...sion, they are receptive to efforts to help them t...them dont really believe that smoking is harmful t...
...ildren are found cherishing coca cola drinks at ho...eloped an uncanny taste petrol! Sajid sne...n Kanpur to steal his cherished drink. Unsurprisin...as while playing outside that he sniffed petrol an...
...iew of data by German researchers,little evidence ...the quality or length of life among adults with di...he drug might worsen complications of the disease ... reported an increased risk of death from cardiova...
Other Medicine News:Health News:Differences in Brain Functions Results in non-contact Knee Injuries 2Health News:Differences in Brain Functions Results in non-contact Knee Injuries 3Health News:Patients Undergoing Tonsillectomy Shows No Change of Taste 2Health News:Female Doctors Facing Barriers to Careers in Education and Research, Study Finds 2Health News:Smokers may Be Motivated to Quit During Interventions in Hospital Stays 2Health News:Smokers may Be Motivated to Quit During Interventions in Hospital Stays 3Health News:Meet the petroholic Boy of Kanpur 2Health News:Avandia Improves Quality of Life in Diabetes Patients 2Health News:Avandia Improves Quality of Life in Diabetes Patients 3
Langerman Phaco Chopper
Minardi Phaco Chopper
Alio-Rosen Phaco PreChopper
Ti/HA Peg & Sleeve System
Medicine Products: